A case of acute haemolysis with 2 different multi target thyrosine kinase inhibitors in a patient with renal cancer.
We report the case of a 78-year-old man diagnosed with metastatic renal cell carcinoma developping acute haemolysis under Sunitinib as well as under Sorafenib. This side effect induced a definitive withdrawal from the drugs. As these drugs are used more widely, rare side effects are bound to appear.